Literature DB >> 11090283

Crystal structure of human GM2-activator protein with a novel beta-cup topology.

C S Wright1, S C Li, F Rastinejad.   

Abstract

GM2 activator protein (GM2-AP) belongs to a small group of non- enzymatic lysosomal proteins that act as cofactors in the sequential degradation of gangliosides. It has been postulated that GM2-AP extracts single GM2 molecules from membranes and presents them in soluble form to beta-hexosaminidase A for cleavage of N-acetyl-d-galactosamine and conversion to GM3. The high affinity of GM2-AP for GM2 is based on specfic recognition of the oligosaccharide moiety as well as the ceramide lipid tail. Genetic defects in GM2-AP result in an atypical form of Tay-Sachs disease known as variant AB GM2 gangliosidosis. The 2.0 A resolution crystal structure of GM2-AP reported here reveals a previously unobserved fold whose main feature is an eight-stranded cup-shaped anti-parallel beta-pleated sheet. The striking feature of the GM2-AP structure is that it possesses an accessible central hydrophobic cavity rather than a buried hydrophobic core. The dimensions of this cavity (12 Ax14 Ax22 A) are suitable for binding 18-carbon lipid acyl chains. Flexible surface loops and a short alpha-helix decorate the mouth of the beta-cup and may control lipid entry to the cavity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090283     DOI: 10.1006/jmbi.2000.4225

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  35 in total

1.  An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A.

Authors:  Maryam Zarghooni; Scott Bukovac; Michael Tropak; John Callahan; Don Mahuran
Journal:  Biochem Biophys Res Commun       Date:  2004-11-19       Impact factor: 3.575

2.  A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates.

Authors:  Michael B Tropak; Scott W Bukovac; Brigitte A Rigat; Sayuri Yonekawa; Warren Wakarchuk; Don J Mahuran
Journal:  Glycobiology       Date:  2009-11-16       Impact factor: 4.313

3.  Structural mechanism for sterol sensing and transport by OSBP-related proteins.

Authors:  Young Jun Im; Sumana Raychaudhuri; William A Prinz; James H Hurley
Journal:  Nature       Date:  2005-09-01       Impact factor: 49.962

4.  Crystal structures of saposins A and C.

Authors:  Victoria E Ahn; Paul Leyko; Jean-René Alattia; Lu Chen; Gilbert G Privé
Journal:  Protein Sci       Date:  2006-07-05       Impact factor: 6.725

5.  Degradation of G(M1) and G(M2) by mammalian sialidases.

Authors:  S C Li; Y T Li; S Moriya; T Miyagi
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

6.  Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

Authors:  Christopher W Cluff; Jory R Baldridge; Axel G Stöver; Jay T Evans; David A Johnson; Michael J Lacy; Valerie G Clawson; Vonnie M Yorgensen; Craig L Johnson; Mark T Livesay; Robert M Hershberg; David H Persing
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 7.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

8.  A Drosophila protein family implicated in pheromone perception is related to Tay-Sachs GM2-activator protein.

Authors:  Elena Starostina; Aiguo Xu; Heping Lin; Claudio W Pikielny
Journal:  J Biol Chem       Date:  2008-10-24       Impact factor: 5.157

Review 9.  Lending a helping hand, screening chemical libraries for compounds that enhance beta-hexosaminidase A activity in GM2 gangliosidosis cells.

Authors:  Michael B Tropak; Don Mahuran
Journal:  FEBS J       Date:  2007-10       Impact factor: 5.542

Review 10.  Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells.

Authors:  Theresa L Gioannini; Jerrold P Weiss
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.